OPKO Health Files 8-K on Financials

Ticker: OPK · Form: 8-K · Filed: Feb 27, 2025 · CIK: 944809

Opko Health, INC. 8-K Filing Summary
FieldDetail
CompanyOpko Health, INC. (OPK)
Form Type8-K
Filed DateFeb 27, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, operations, sec-filing

Related Tickers: OPK

TL;DR

OPKO Health dropped its 8-K on Feb 27, 2025, with financial and operational updates.

AI Summary

On February 27, 2025, OPKO Health, Inc. filed an 8-K report detailing its financial results and operations. The filing includes information on the company's financial condition and statements, as well as exhibits related to these matters. OPKO Health, Inc. is incorporated in Delaware and headquartered in Miami, Florida.

Why It Matters

This filing provides investors with crucial updates on OPKO Health's financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for OPKO Health, Inc.?

The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.

On what date was this 8-K report filed or effective?

The report was filed as of February 27, 2025.

Where are OPKO Health, Inc.'s principal executive offices located?

The principal executive offices are located at 4400 Biscayne Blvd., Miami, Florida 33137.

In which state is OPKO Health, Inc. incorporated?

OPKO Health, Inc. is incorporated in Delaware.

What is the SIC code associated with OPKO Health, Inc.?

The Standard Industrial Classification (SIC) code for OPKO Health, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding OPKO HEALTH, INC. (OPK).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing